Mindmaze SA
8
2
2
5
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
High Risk
Score: 60/100
12.5%
1 terminated/withdrawn out of 8 trials
83.3%
-3.2% vs industry average
0%
0 trials in Phase 3/4
0%
0 of 5 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (8)
SwissNeuroRehab - HDHI
Role: collaborator
Virtual-reality Exercises for Alleviating Attention Deficits in Patients With Acquired Brain Injury
Role: lead
Cardio-visual Stimulation in Augmented Reality for Pain Reduction
Role: collaborator
The StayFitLonger Study: an Innovative Computerized Home-based Training to Foster Independent Life at Home
Role: collaborator
Virtual Reality Intervention Alleviates Dyspnea in Patients Recovering From COVID Pneumonia
Role: collaborator
Exergames Balance Program in Neurorehabilitation
Role: collaborator
Study Evaluating the MindMotionPRO for Early Post-stroke Upper-limb Rehabilitation
Role: lead
Immersive Virtual Reality for Stroke Motor Rehabilitation
Role: lead
All 8 trials loaded